Success Metrics

Active Trials
1(25%)

Phase Distribution

Ph not_applicable
1
25%
Ph phase_3
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
3(75.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Other(3)

Detailed Status

unknown3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
N/A
Most Advanced
Phase 3

Trials by Phase

Phase 33 (75.0%)
N/A1 (25.0%)

Trials by Status

recruiting125%
unknown375%

Recent Activity

1 active trials
Showing 4 of 4
recruitingphase_3

Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma

NCT05979961
unknownphase_3

Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC

NCT03366415
unknownnot_applicable

Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma

NCT02627807
unknownphase_3

Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

NCT01872962

Clinical Trials (4)

Showing 4 of 4 trials
NCT05979961Phase 3

Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal Carcinoma

Recruiting
NCT03366415Phase 3

Sequential or Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced NPC

Unknown
NCT02627807Not Applicable

Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma

Unknown
NCT01872962Phase 3

Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
4